David Nicholson

David Nicholson

Direktor/Vorstandsmitglied bei ACTINIUM PHARMACEUTICALS, INC.

Vermögen: 493 $ am 31.10.2026

72 Jahre
Health Technology
Commercial Services
Finance

Profil

David C.
Nicholson
is Chairman at Exscientia AI Ltd. since 2020.
He is Non-Executive Chairman at Wild Bioscience Ltd. starting in 2023.
He serves as Director at Rapalogix Health, Inc., Science Exchange, Inc. since 2018, Tarus Therapeutics, Inc. since 2020, and Volastra Therapeutics, Inc. He is Lead Independent Director at Actinium Pharmaceuticals, Inc. since 2017.
He is also an Operational Partner at Gilde Healthcare Partners, Inc. since 2020.
Former roles include Non-Executive Chairman at Exscientia Ltd. from 2023 to 2024, Independent Director at Adverum Biotechnologies, Inc. from 2023 to 2025, Director at Cactus Ventures, Inc. from 2012 to 2013, Vice President-Licensing & Knowledge Management at Merck & Co., Inc. from 2009 to 2011, SVP-Global Project Management & Drug Safety at Schering-Plough Corp.
USA from 2007 to 2009, Chief Technology Officer & Executive VP at Bayer CropScience AG from 2012 to 2014, Executive VP-Research & Development at Organon International, Inc. from 1988 to 2007, Executive VP-Research & Development at Organon Biosciences, Inc. in 2007, Executive VP, Chief Research & Development Officer at Allergan UC from 2015 to 2020, CTO, Head-Research & Development at Bayer Crop Science Solutions LLC from 2012 to 2014, Vice Chairman at Transcelerate Biopharma, Inc., Director at Actinium Pharmaceuticals, Inc., Senior Vice President at Forest Laboratories, Inc. Education includes an undergraduate degree from The University of Manchester in 1975 and a doctorate from The University of Wales in 1980.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
02.10.2026 333 ( 0% ) 493 $ 31.10.2026

Aktive Positionen von David Nicholson

UnternehmenPositionBeginn
ACTINIUM PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 01.01.2008
Vorsitzender 01.10.2020
Vorsitzender 03.11.2023
Direktor/Vorstandsmitglied 28.06.2018
Direktor/Vorstandsmitglied 14.05.2020
Direktor/Vorstandsmitglied -
Private Equity Investor 01.09.2020

Ehemalige bekannte Positionen von David Nicholson

UnternehmenPositionEnde
ADVERUM BIOTECHNOLOGIES, INC. Direktor/Vorstandsmitglied 09.12.2025
EXSCIENTIA PLC Vorsitzender 12.02.2024
░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von David Nicholson im Detail an

Ausbildung von David Nicholson

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

81

Beziehungen ersten Grades

22

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen22

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Process Industries

Health Technology

Consumer Services

Organon Biosciences, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

  1. Börse
  2. Insider
  3. David Nicholson